Citation Impact
Citing Papers
Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling
2009
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
2004
Clinical management of adrenocortical carcinoma
2009
Italian consensus for the classification and reporting of thyroid cytology
2014 Standout
Review of therapeutic drug monitoring of anticancer drugs part 1 – Cytotoxics
2014
Thyroid cancer
2016 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
FDG PET in the Management of Patients with Adrenal Masses and Adrenocortical Carcinoma
2011
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancer
2002
Is There a Role for Unstimulated Thyroglobulin Velocity in Predicting Recurrence in Papillary Thyroid Carcinoma Patients with Detectable Thyroglobulin after Radioiodine Ablation?
2012
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period
2008 Standout
Merits and pitfalls of mifepristone in Cushing's syndrome
2009
Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan
2006
Cushing's syndrome
2001
Prediction of Disease Status by Recombinant Human TSH-Stimulated Serum Tg in the Postsurgical Follow-Up of Differentiated Thyroid Carcinoma
2001
Cushing's syndrome
2015 Standout
Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma
2009
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
Pacientes tratados por carcinoma diferenciado de tiroides con rastreos de 131I negativos y niveles de tiroglobulina elevada. Una evolución posible
2007
Levothyroxine Suppression of Thyroglobulin in Patients with Differentiated Thyroid Carcinoma1
1999
The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis
2012 Standout
Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data
2013
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
2002
Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients
2007
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
2003
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS
2017 Standout
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking
2007
Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer
2009
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias
2007
Are Posttherapy Radioiodine Scans Informative and Do They Influence Subsequent Therapy of Patients with Differentiated Thyroid Cancer?
2000
ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee
2017 Standout
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Preoperative Diagnosis of Benign Thyroid Nodules with Indeterminate Cytology
2012 Standout
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference
2008 Standout
Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
2012
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
Reversibility of ′Secondary Hypercalcitoninemia′ After Kidney Transplantation
2005
SERUM THYROGLOBULIN MEASUREMENT
2001
Cushing's syndrome
2006 Standout
Management of Thyroid Cancer: Radioiodine Ablation, “Stunning,” and Treatment of Thyroglobulin-Positive, 131I Scan-Negative Patients
2000
Basal Calcitonin Levels and the Response to Pentagastrin Stimulation in Patients After Kidney Transplantation or on Chronic Hemodialysis as Indicators of Medullary Carcinoma
1999
Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome
2011
Long-Term Survival After Adrenalectomy for Stage I/II Adrenocortical Carcinoma (ACC): A Retrospective Comparative Cohort Study of Laparoscopic Versus Open Approach
2013
Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia
2006
Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma
1998
European Guidelines for Obesity Management in Adults
2015 Standout
Should ‘low‐risk’ thyroid cancer patients with residual thyroglobulin be re‐treated with iodine 131?
2006
Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma
1998
Post I-131 Therapy Scanning in Patients With Thyroid Carcinoma Metastases: An Unnecessary Cost or a Relevant Contribution?
2004
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Dosimetrically Determined Doses of Radioiodine for the Treatment of Metastatic Thyroid Carcinoma
2002
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
The 2017 Bethesda System for Reporting Thyroid Cytopathology
2017 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Thyroglobulin in the Washout Fluid of Lymph-Node Biopsy: What Is Its Role in the Follow-Up of Differentiated Thyroid Carcinoma?
2013
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Current Controversies in the Management of Pediatric Patients with Well-Differentiated Nonmedullary Thyroid Cancer: A Review
2002
Resistance of [ 18 F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
2001
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Clinical Outcomes Following Empiric Radioiodine Therapy in Patients with Structurally Identifiable Metastatic Follicular Cell–Derived Thyroid Carcinoma with Negative Diagnostic But Positive Post-Therapy 131 I Whole-Body Scans
2012
2015
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma
2000
Diagnostic 131-Iodine Whole-Body Scan May Be Avoided in Thyroid Cancer Patients Who Have Undetectable Stimulated Serum Tg Levels After Initial Treatment
2002
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
2017 Standout
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
2006
Update in Adrenocortical Carcinoma
2013
Adrenocortical carcinoma: a clinician's update
2011
Adrenocortical cancer: pathophysiology and clinical management
2007
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
2005
Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors
2013 Standout
Response of thyroglobulin to radioiodine therapy in thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome.
2011
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Cancer treatment and survivorship statistics, 2019
2019 Standout
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
2004
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Lack of Impact of Radioiodine Therapy in Tg-Positive, Diagnostic Whole-Body Scan-Negative Patients with Follicular Cell-Derived Thyroid Cancer
2002
Radioiodine therapy for differentiated thyroid carcinoma with thyroglobulin positive and radioactive iodine negative metastases
2009
Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
2004
The interpretation of 131I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings
2003
A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
2003
Genetic aspects of adrenocortical tumours and hyperplasias
2012
Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer.
2004
Guidelines for the management of thyroid cancer
2014 Standout
Adrenocortical Carcinoma
2013
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
2016 Standout
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Mutations of β-Catenin in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors
2005
Outcome of Differentiated Thyroid Cancer with Detectable Serum Tg and Negative Diagnostic 131I Whole Body Scan: Comparison of Patients Treated with High 131I Activities Versus Untreated Patients
2001
Thyroid carcinoma
2003 Standout
Works of Eric Baudin being referenced
131 I Therapy for Elevated Thyroglobulin Levels
1997
Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors
2001
Pentagastrin Testing in Patients with Renal Insufficiency: Normal Responsivity of Mature Calcitonin
1998
Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma
1998
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2012
Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of Malignancy
2005
Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma
2001